Lanean...
The development of oral semaglutide, an oral GLP-1 analog, for the treatment of type 2 diabetes
Glucagon-like peptide-1 receptor agonists (GLP-1RA) are effective agents for achieving glycemic control. Oral semaglutide is the first oral formulation of a GLP-1RA to be approved in the USA. This agent may lead to earlier initiation of GLP-1RA therapy in the type 2 diabetes continuum of care, and r...
Gorde:
| Argitaratua izan da: | Diabetol Int |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Singapore
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7082439/ https://ncbi.nlm.nih.gov/pubmed/32206477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-019-00423-8 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|